Suppression of p38a MAPK signaling in osteoblast lineage cells impairs bone anabolic action of parathyroid hormone

C Thouverey, J Caverzasio
Journal of Bone and Mineral Research, 2015

Intermittent parathyroid hormone administration (iPTH) increases bone mass and strength by stimulating osteoblast number and activity. PTH exerts its anabolic effects through cAMP/protein kinase A (PKA) signaling pathway in mature osteoblasts and osteocytes. Here, we show that inactivation of the p38a MAPK-encoding gene with the use of an osteocalcin-cre transgene prevents iPTH bone anabolic action. Indeed, iPTH fails to increase insulin-like growth factor 1 expression, osteoblast number and activity, and bone formation in mice lacking p38a in osteoblasts and osteocytes. Moreover, iPTH-induced expression of receptor activator of NF-¿B ligand (RANKL) and subsequent increased bone resorption are suppressed in those mice. Finally, we found that PTH activates p38a MAPK downstream of cAMP/PKA signaling pathway in mature osteoblasts. Our findings identify p38a MAPK as a key component of PTH signaling in osteoblast lineage cells and highlight its requirement in iPTH osteoanabolic activity. © 2015 American Society for Bone and Mineral Research.

Read more »

Journal of Bone and Mineral Research
DOI: 10.1002/jbmr.2762
University Hospital of Geneva